| Financial Year |
March 31 2023 |
| Monetary Funds |
943,115,323.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,253,096.50 |
| Accounts Receivable |
35,632,088.07 |
| Advances to Suppliers |
8,101,444.10 |
| Other Receivables |
83,032,383.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
39,994,774.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
18,000,000.00 |
| Other Current Assets |
10,165,055.33 |
| Total Current Assets |
1,249,280,441.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
222,395,684.94 |
| Investment Properties |
9,388,488.50 |
| Fixed Assetes |
1,899,151,165.22 |
| Under-construction Projects |
285,733,216.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
207,450,755.57 |
| R&D expenses |
-- |
| Goodwill |
4,506,434.45 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
26,397,828.22 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,656,231,757.46 |
| Total Assets |
3,905,512,198.55 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
348,235,194.54 |
| Accounts Received In Advance |
500,189.18 |
| Employee Compensation Payable |
19,315,431.94 |
| Taxes Payable |
33,895,008.35 |
| Interest Payable |
-- |
| Dividend Payable |
61,837.51 |
| Other payables |
124,925,906.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,000,000.00 |
| Other Current Liabilities |
25,352,934.71 |
| Sub-Total of Current Liabilities |
868,228,701.78 |
| Long-term Loans |
50,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
200,576,409.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,028,724.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
310,101,467.87 |
| Total Liabilities |
1,178,330,169.65 |
| Paid-In Capital(Or Share Stock) |
421,432,670.00 |
| Capital Surplus |
510,812,781.47 |
| Surplus Reserve |
172,219,336.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,585,316,954.33 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,727,182,028.90 |
| Owner's Equity（Stockholder's Equity） |
2,727,182,028.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,905,512,198.55 |
